Results 151 to 160 of about 3,178,532 (212)

Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease. Comparison with a beta-adrenergic agent.

American Review of Respiratory Disease, 1987
Adrenergic bronchodilators have the potential drawback that they may increase hypoxemia in spite of relieving air-flow obstruction in patients with asthma.
Nicholas J. Gross, Z. Bankwala
semanticscholar   +1 more source

[Tiotropium, a long-acting bronchodilating agent for the treatment of COPD].

Nederlands tijdschrift voor geneeskunde, 2006
The goals of COPD management according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline are: prevention of disease progression, relief of symptoms, improvement of exercise tolerance and the quality of life, prevention and treatment of exacerbations and complications, and reduction of mortality and adverse effects.
Schuurbiers, O.C.J., Schermer, T.R.J., Dekhuijzen, P.N.R., Weel, C. van   +3 more
openaire   +2 more sources

Design and synthesis of new 8-anilide theophylline derivatives as bronchodilators and antibacterial agents

Archives of Pharmacal Research, 2012
Theophylline derivatives have long been recognized as potent bronchodilators for the relief of acute asthma. Recently, it was found that bacterial infection has a role in asthma pathogenesis. The present work involves the design and synthesis of 8-substituted theophylline derivatives as bronchodilators and antibacterial agents.
Abdel Alim M. Abdel Alim, Ahmad Talhouni, Alaa M. Hayallah   +2 more
openaire   +3 more sources

Effects of bronchospastic and bronchodilator agents on guinea pig trachobronchial smooth muscle

1976
Bibliography: p. 100-115.
openaire   +3 more sources

A Brief Review of Sympathomimetic Bronchodilators and a Description of a New Selective Agent, Rimiterol Hydrobromide

Respiration, 1978
The development of beta2-specific sympathomimetic bronchodilators (rimiterol, salbutamol, terbutaline) has made the basic treatment of asthmatic patients more safe and effective. Despite that, the asthmatics should be under careful control and all patients should be taught the correct way to use their bronchodilator aerosols.
openaire   +2 more sources

A comparative study of two parasympatholytic bronchodilator agents: ipratropium bromide and diphemanil methylsulfate.

Journal of Pharmacology and Experimental Therapeutics, 1981
L. Diamond, M. O'Donnell
semanticscholar   +1 more source

Beta2-adrenergic receptor polymorphisms as a determinant of preferential bronchodilator responses to &bgr;2-agonist and anticholinergic agents in Japanese patients with chronic obstructive pulmonary disease

Pharmacogenetics & Genomics, 2011
S. Konno, H. Makita, Masaru Hasegawa, Y. Nasuhara, K. Nagai, T. Betsuyaku, N. Hizawa, M. Nishimura   +7 more
semanticscholar   +1 more source

Anticholinergic agents in asthma: chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling

Current opinion in pulmonary medicine, 2006
H. Kanazawa
semanticscholar   +1 more source

Acute bronchodilator response to a combination of beta-adrenergic and anticholinergic agents in patients with cystic fibrosis.

Jornal de Pediatria, 1992
I. Sánchez, J. Holbrow, V. Chernick
semanticscholar   +1 more source

Bronchodilating Agents

Acta Clinica Belgica, 1985
openaire   +2 more sources